Novavax, Inc. (NVAX) Up 5.56% in Premarket Trading

Novavax, Inc. (NVAX) has gained Wednesday morning, with the stock climbing 5.56% in pre-market trading to 81.5. NVAX's short-term technical score of 34 indicates that the stock has traded less bullishly over the last month than 66% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 63% of stocks. Novavax, Inc. has fallen 56.44% over the past month, closing at $153.25 on December 29. During this period of time, the stock fell as low as $77.21 and as high as $159.00. NVAX has an average analyst recommendation of Strong Buy. The company has an average price target of $270.00.

NVAX has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on NVAX!

See Full NVAX Report

Novavax, Inc. has a Long-Term Technical rank of 9. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 91% of the market scoring higher. In the Biotechnology industry which is number 143 by this metric, NVAX ranks better than 27% of stocks.

Important Dates for Investors in NVAX:

-Novavax, Inc. is set to release earnings on 3/7/2022. During their last earnings release the company posted EPS of $-14.99. -We do not have a set dividend date for Novavax, Inc. at this time. Click Here To Get The Full Report on Novavax, Inc. (NVAX)